Bronchoscopic aspects of renal cell carcinoma (RCC)

被引:0
|
作者
Dobbertin, I
Dierkesmann, R
Kwiatkowski, J
Reichardt, W
机构
[1] Klin Pneumol & Thoraxchirurg, Klin Schillerhohe, D-70839 Gerlingen, Germany
[2] Klin Pneumol & Thoraxchirurg, Klin Schillerhohe, D-70839 Gerlingen, Germany
[3] Katharinenhosp, Radiol Klin, D-70174 Stuttgart, Germany
关键词
renal cell carcinoma; bronchoscopic tumor treatment; endobronchial brachytherapy; angiography of bronchial artery; haemoptysis; metastatic bronchopulmonay tumors;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A symposium on RCC in July 1998 in Tubingen was where we to reviewed our patients with endobronchial metastatic RCC treated by bronchoscopy since 1981. 24 of 26 consecutive cases are the subject of the present study. Tumor history, X-ray findings, endobronchial appearance, treatment and the pathogenetic mechanisms of this special form of metastatic spread are demonstrated and discussed. In 5 patients > 10 years relapsed between nephrectomy and bronchoscopic tumor therapy. A thrombuslike tumor growth and bleeding were striking bronchoscopic features. In X-my besides atelectasis, hilar or mediastinal masses were seen half of the patients, in 50% without parenchymal lung nodes, suggesting lymphogenic spread In several patients bronchial recanalisation could be successfully repeated over long periods. Abnormal X-ray, haemoptysis or dyspnoa in patients with RCC demands bronchoscopy. In case of bronchial tumor obstruction bronchoscopic treatment offers excellent palliation.
引用
收藏
页码:1567 / 1572
页数:6
相关论文
共 50 条
  • [31] Medullary renal cell carcinoma (RCC): Genomics and treatment outcomes
    Carlo, Maria Isabel
    Chen, Yingbei
    Chaim, Joshua
    Coskey, Devyn Taylor
    Woo, Kaitlin
    Hsieh, James
    Voss, Martin Henner
    Feldman, Darren R.
    Motzer, Robert J.
    Lee, Chung-Han
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Bevacizumab with or without erlotinib in metastatic renal cell carcinoma (RCC).
    Bukowski, R. M.
    Kabbinavar, F.
    Figlin, R. A.
    Flaherty, K.
    Srinivas, S.
    Vaishampayan, U.
    Drabkin, H.
    Dutcher, J.
    Scappaticci, F.
    McDermott, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 222S - 222S
  • [33] Surgical management of renal cell carcinoma (RCC) with venous invasion
    Davydov, M., I
    Matveev, V. B.
    Figurin, K. M.
    Volkova, M., I
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E88 - E88
  • [35] Emerging monoclonal antibodies for the treatment of renal cell carcinoma (RCC)
    Atkins, Michael B.
    Philips, George K.
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (03) : 243 - 254
  • [37] Rapamycin mechanisms of action in renal clear cell carcinoma (RCC)
    Balducci, L
    Lambo, R
    Saldarelli, M
    Mancini, V
    Battaglia, M
    Ambrosi, A
    Dambrosio, M
    Pontrelli, P
    Stallone, G
    Grandaliano, G
    Schena, FP
    Gesualdo, L
    Ranieri, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V203 - V203
  • [38] Renal cell carcinoma (RCC) spreading to the larynx: an unusual condition
    Teran, Alfonso Ivan Sanchez
    Zamorano, Monserrat Martinez
    Ortiz, Jose Abraham Trujillo
    Arriaga, Jacqueline Cerna
    BMJ CASE REPORTS, 2024, 17 (01)
  • [39] Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC)
    Ko, Kyungtae
    Park, Young H.
    Lee, Jeong W.
    Ku, Ja H.
    Kwak, Cheol
    Kim, Hyeon H.
    BJU INTERNATIONAL, 2013, 112 (06) : 775 - 780
  • [40] Combined mTOR and AKT inhibition in renal cell carcinoma (RCC)
    Holland, W. S.
    Mack, P. C.
    Tepper, C. G.
    Gandara, D. R.
    Lara, P., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)